title: The use of topical 5% imiquimod during pregnancy: a case series.
authors.forename: A
authors.initials: A
authors.lastname: Einarson
authors.forename: A
authors.initials: A
authors.lastname: Costei
authors.forename: S
authors.initials: S
authors.lastname: Kalra
authors.forename: M
authors.initials: M
authors.lastname: Rouleau
authors.forename: G
authors.initials: G
authors.lastname: Koren
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000287:Administration, Topical; D000328:Adult; D000634:Aminoquinolines / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003218:Condylomata Acuminata / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077271:Imiquimod; D007369:Interferon Inducers / Q000627:therapeutic use; D011247:Pregnancy; D014860:Warts / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D007369:Interferon Inducers; D000077271:Imiquimod